Clinical Trials
30 trialsTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
PERSIST
AvenCell Therapeutics, Inc.
CALySSEY
Baylor College of Medicine
The Florida ASCENT Study
University of Florida
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
DETERMINE
Cancer Research UK
DETERMINE
Cancer Research UK
A Multi-center Investigation of Family Health.
Odense University Hospital
EARN
Washington University School of Medicine
Lighting Intervention for Cancer-related Fatigue
University of Michigan Rogel Cancer Center
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
IIT2020-20-SHIRAZIP-WALK: Nature Walks
Cedars-Sinai Medical Center
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
National Cancer Institute (NCI)
Genetics in the Progression of Nephropathies
Ospedale San Raffaele
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
Audubon Bioscience
Hypertension Management in Cancer Patients
Duke University
GBCPRT0008
Global BioClinical
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Celgene
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Acrotech Biopharma Inc.
Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer
Aprea Therapeutics
N1
CureOne
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation
University of Arizona
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
M.D. Anderson Cancer Center
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Stanford University
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
University of California, San Francisco
Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)
University of Liege